GPs could be influenced by pharma, King's Fund warns

packets of pills

GP prescribing could become commercially biased if clinical commissioning groups buy in support from drug companies, a report commissioned by the King’s Fund has warned.

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access